Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-06-01 @ 1:01 PM
Study NCT ID:
NCT06109467
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2023-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
Sponsor:
Organization: